Logo image of LGCB

LINKAGE GLOBAL INC (LGCB) Stock Fundamental Analysis

NASDAQ:LGCB - Nasdaq - KYG5500B1288 - Common Stock - Currency: USD

2.6408  +0.03 (+1.18%)

Fundamental Rating

2

Overall LGCB gets a fundamental rating of 2 out of 10. We evaluated LGCB against 28 industry peers in the Broadline Retail industry. While LGCB seems to be doing ok healthwise, there are quite some concerns on its profitability. LGCB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year LGCB has reported negative net income.
LGCB had a negative operating cash flow in the past year.
LGCB Yearly Net Income VS EBIT VS OCF VS FCFLGCB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1M -1M -2M -3M

1.2 Ratios

With a Return On Assets value of -3.46%, LGCB is not doing good in the industry: 60.71% of the companies in the same industry are doing better.
The Return On Equity of LGCB (-6.25%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -3.46%
ROE -6.25%
ROIC N/A
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)4.69%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LGCB Yearly ROA, ROE, ROICLGCB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 10 -10 20 30

1.3 Margins

LGCB has a Gross Margin (40.49%) which is in line with its industry peers.
The Profit Margin and Operating Margin are not available for LGCB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LGCB Yearly Profit, Operating, Gross MarginsLGCB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 10 20 30 40

6

2. Health

2.1 Basic Checks

LGCB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LGCB has been increased compared to 1 year ago.
The debt/assets ratio for LGCB has been reduced compared to a year ago.
LGCB Yearly Shares OutstandingLGCB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 500K 1M 1.5M 2M
LGCB Yearly Total Debt VS Total AssetsLGCB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

LGCB has an Altman-Z score of 3.78. This indicates that LGCB is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of LGCB (3.78) is better than 67.86% of its industry peers.
LGCB has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
LGCB's Debt to Equity ratio of 0.26 is in line compared to the rest of the industry. LGCB outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 3.78
ROIC/WACCN/A
WACC5.58%
LGCB Yearly LT Debt VS Equity VS FCFLGCB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

A Current Ratio of 2.73 indicates that LGCB has no problem at all paying its short term obligations.
The Current ratio of LGCB (2.73) is better than 82.14% of its industry peers.
LGCB has a Quick Ratio of 2.71. This indicates that LGCB is financially healthy and has no problem in meeting its short term obligations.
LGCB has a Quick ratio of 2.71. This is amongst the best in the industry. LGCB outperforms 92.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.71
LGCB Yearly Current Assets VS Current LiabilitesLGCB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M 10M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.43% over the past year.
LGCB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.19%.
EPS 1Y (TTM)36.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%165.38%
Revenue 1Y (TTM)-19.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-56.87%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LGCB Yearly Revenue VS EstimatesLGCB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 5M 10M 15M 20M

0

4. Valuation

4.1 Price/Earnings Ratio

LGCB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LGCB Price Earnings VS Forward Price EarningsLGCB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

LGCB's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. LGCB is more expensive than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 81.14
LGCB Per share dataLGCB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LGCB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LINKAGE GLOBAL INC

NASDAQ:LGCB (8/8/2025, 8:00:02 PM)

2.6408

+0.03 (+1.18%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.2%
Inst Owner ChangeN/A
Ins Owners82.06%
Ins Owner ChangeN/A
Market Cap20.02M
AnalystsN/A
Price TargetN/A
Short Float %6.22%
Short Ratio5.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.95
P/FCF N/A
P/OCF N/A
P/B 2.85
P/tB 2.85
EV/EBITDA 81.14
EPS(TTM)-0.21
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS1.36
BVpS0.93
TBVpS0.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.46%
ROE -6.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.49%
FCFM N/A
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)4.69%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 7.82
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 2.71
Altman-Z 3.78
F-Score4
WACC5.58%
ROIC/WACCN/A
Cap/Depr(3y)198.18%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.76%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%165.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-56.87%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y89.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.89%
OCF growth 3YN/A
OCF growth 5YN/A